High‐dose mizoribine combined with calcineurin inhibitor (cyclosporine or tacrolimus), basiliximab and corticosteroids for renal transplantation: A Japanese multicenter study

Publisher： John Wiley & Sons Inc

E-ISSN： 1442-2042|25|2|141-145

ISSN： 0919-8172

Source： INTERNATIONAL JOURNAL OF UROLOGY, Vol.25, Iss.2, 2018-02, pp. : 141-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcineurin inhibitor‐associated electrolyte disturbances after pediatric renal transplantation: Could fludrocortisone therapy have a role?

By  

PEDIATRIC TRANSPLANTATION, Vol. 22, Iss. 2, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Study of bone metabolism and angiogenesis in patients undergoing high‐dose chemotherapy/autologous hematopoietic stem cell transplantation

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 2, 2018-02 ,pp. : 131-139

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tacrolimus reduction with everolimus addition for calcineurin inhibitor‐induced arteriolopathy in kidney allografts

By  

NEPHROLOGY, Vol. 20, Iss. S2, 2015-07 ,pp. : 58-60

John Wiley & Sons Inc

Access to resources Recommend Favorite

The efficacy and safety of cyclosporine reduction in de novo renal allograft patients receiving sirolimus and corticosteroids: results from an open‐label comparative study

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 27, Iss. 2, 2014-02 ,pp. : 176-186

John Wiley & Sons Inc

Access to resources Recommend Favorite

Calcineurin inhibitor‐sparing regimens based on mycophenolic acid after kidney transplantation

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 8, 2015-08 ,pp. : 928-937

John Wiley & Sons Inc

Access to resources Recommend Favorite